Alterity Therapeutics Statistics

Total Valuation

ATHE has a market cap or net worth of $33.45 million. The enterprise value is $30.66 million.

Market Cap	33.45M
Enterprise Value	30.66M

Important Dates

The last earnings date was Saturday, February 15, 2025, after market close.

Earnings Date	Feb 15, 2025
Ex-Dividend Date	n/a

Share Statistics

ATHE has 5.32 billion shares outstanding. The number of shares has increased by 104.33% in one year.

Current Share Class	n/a
Shares Outstanding	5.32B
Shares Change (YoY)	+104.33%
Shares Change (QoQ)	+10.82%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	4.90B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.51
Forward PS	n/a
PB Ratio	6.94
P/TBV Ratio	6.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	13.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.84, with a Debt / Equity ratio of 0.01.

Current Ratio	3.84
Quick Ratio	3.76
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -155.77% and return on invested capital (ROIC) is -99.57%.

Return on Equity (ROE)	-155.77%
Return on Assets (ROA)	-78.37%
Return on Invested Capital (ROIC)	-99.57%
Return on Capital Employed (ROCE)	-262.19%
Revenue Per Employee	$230,490
Profits Per Employee	-$1.22M
Employee Count	10
Asset Turnover	0.23
Inventory Turnover	n/a

Taxes

In the past 12 months, ATHE has paid $28,522 in taxes.

Income Tax	28,522
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +53.62% in the last 52 weeks. The beta is 0.48, so ATHE's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	+53.62%
50-Day Moving Average	3.86
200-Day Moving Average	2.24
Relative Strength Index (RSI)	34.30
Average Volume (20 Days)	17,914

Short Selling Information

Short Interest	54,586
Short Previous Month	101,807
Short % of Shares Out	0.51%
Short % of Float	n/a
Short Ratio (days to cover)	1.58

Income Statement

In the last 12 months, ATHE had revenue of $2.30 million and -$12.25 million in losses. Loss per share was -$0.00.

Revenue	2.30M
Gross Profit	2.19M
Operating Income	-12.70M
Pretax Income	-8.09M
Net Income	-12.25M
EBITDA	-12.68M
EBIT	-12.70M
Loss Per Share	-$0.00

Full Income Statement

Balance Sheet

The company has $2.81 million in cash and $65,494 in debt, giving a net cash position of $2.74 million or $0.00 per share.

Cash & Cash Equivalents	2.81M
Total Debt	65,494
Net Cash	2.74M
Net Cash Per Share	$0.00
Equity (Book Value)	4.82M
Book Value Per Share	0.00
Working Capital	4.77M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-10.19M
Capital Expenditures	n/a
Free Cash Flow	-10.33M
FCF Per Share	-$0.00

Full Cash Flow Statement

Margins

Gross Margin	95.14%
Operating Margin	-551.15%
Pretax Margin	-530.10%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ATHE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-104.33%
Shareholder Yield	-104.33%
Earnings Yield	-36.62%
FCF Yield	-30.88%

Analyst Forecast

The average price target for ATHE is $12.00, which is 277.36% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.00
Price Target Difference	277.36%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 9, 2023. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jan 9, 2023
Split Type	Reverse
Split Ratio	0.1:1

Scores

ATHE has an Altman Z-Score of -29.73 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-29.73
Piotroski F-Score	3